JP2023521492A5 - - Google Patents
Info
- Publication number
- JP2023521492A5 JP2023521492A5 JP2022563036A JP2022563036A JP2023521492A5 JP 2023521492 A5 JP2023521492 A5 JP 2023521492A5 JP 2022563036 A JP2022563036 A JP 2022563036A JP 2022563036 A JP2022563036 A JP 2022563036A JP 2023521492 A5 JP2023521492 A5 JP 2023521492A5
- Authority
- JP
- Japan
- Prior art keywords
- therapeutic agent
- daytime
- dalidrexant
- agent according
- sleep
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2020060940 | 2020-04-19 | ||
| EPPCT/EP2020/060940 | 2020-04-19 | ||
| PCT/EP2021/059943 WO2021213923A1 (en) | 2020-04-19 | 2021-04-16 | Medical use of daridorexant |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023521492A JP2023521492A (ja) | 2023-05-24 |
| JP2023521492A5 true JP2023521492A5 (https=) | 2024-04-25 |
| JP7822954B2 JP7822954B2 (ja) | 2026-03-03 |
Family
ID=75478068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022563036A Active JP7822954B2 (ja) | 2020-04-19 | 2021-04-16 | ダリドレキサントの医学的用途 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20230134935A1 (https=) |
| EP (1) | EP4138822A1 (https=) |
| JP (1) | JP7822954B2 (https=) |
| KR (1) | KR20230004670A (https=) |
| CN (1) | CN115427037A (https=) |
| AU (1) | AU2021260018A1 (https=) |
| BR (1) | BR112022020924A2 (https=) |
| CA (1) | CA3175369A1 (https=) |
| CL (1) | CL2022002855A1 (https=) |
| IL (1) | IL297234A (https=) |
| MX (1) | MX2022011179A (https=) |
| PH (1) | PH12022552763A1 (https=) |
| TW (1) | TW202200133A (https=) |
| WO (1) | WO2021213923A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115925699B (zh) * | 2022-02-25 | 2023-10-03 | 南京知和医药科技有限公司 | 具有镇痛活性的稠环化合物及其制备方法与用途 |
| WO2024019978A2 (en) * | 2022-07-19 | 2024-01-25 | Rutgers, The State University Of New Jersey | Therapeutic combinations and methods |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013502447A (ja) * | 2009-08-24 | 2013-01-24 | グラクソ グループ リミテッド | 睡眠障害の治療のためのオレキシン受容体アンタゴニストとしての５−メチル−ピペリジン誘導体 |
| ES2617863T3 (es) | 2012-06-04 | 2017-06-20 | Actelion Pharmaceuticals Ltd. | Derivados de bencimidazol-prolina |
| MY179862A (en) | 2013-12-03 | 2020-11-18 | Idorsia Pharmaceuticals Ltd | Crystalline form of (s)-(2-(6-chloro-7-methyl-1h-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1 -yl)(5-methoxy-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone and its use as orexin receptor antagonists |
| UA119151C2 (uk) | 2013-12-03 | 2019-05-10 | Ідорсія Фармасьютікалз Лтд | КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА |
| SI3077391T1 (sl) | 2013-12-04 | 2018-11-30 | Idorsia Pharmaceuticals Ltd | Uporaba benzimidazol-prolinskih derivatov |
| ES2843952T3 (es) | 2014-10-23 | 2021-07-21 | Eisai R&D Man Co Ltd | Composiciones para tratar el insomnio |
| LT3619199T (lt) | 2017-05-03 | 2021-09-27 | Idorsia Pharmaceuticals Ltd | 2-([1,2,3]triazol-2-il)-benzenkarboksirūgšties darinių gamyba |
-
2021
- 2021-04-16 EP EP21718142.9A patent/EP4138822A1/en active Pending
- 2021-04-16 WO PCT/EP2021/059943 patent/WO2021213923A1/en not_active Ceased
- 2021-04-16 IL IL297234A patent/IL297234A/en unknown
- 2021-04-16 PH PH1/2022/552763A patent/PH12022552763A1/en unknown
- 2021-04-16 BR BR112022020924A patent/BR112022020924A2/pt not_active Application Discontinuation
- 2021-04-16 KR KR1020227040124A patent/KR20230004670A/ko active Pending
- 2021-04-16 AU AU2021260018A patent/AU2021260018A1/en active Pending
- 2021-04-16 US US17/996,499 patent/US20230134935A1/en active Pending
- 2021-04-16 CN CN202180028992.7A patent/CN115427037A/zh active Pending
- 2021-04-16 JP JP2022563036A patent/JP7822954B2/ja active Active
- 2021-04-16 CA CA3175369A patent/CA3175369A1/en active Pending
- 2021-04-16 MX MX2022011179A patent/MX2022011179A/es unknown
- 2021-04-19 TW TW110113975A patent/TW202200133A/zh unknown
-
2022
- 2022-10-17 CL CL2022002855A patent/CL2022002855A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111201014A (zh) | 治疗过度嗜睡的方法和组合物 | |
| Harrington et al. | Sleep and older patients | |
| JP2017510607A5 (https=) | ||
| JP2008509224A5 (https=) | ||
| JP2010513250A5 (https=) | ||
| JP2023521492A5 (https=) | ||
| RU2009119258A (ru) | Способ лечения воспалительных заболеваний кишечника | |
| ES2317196T3 (es) | Metodo para tratar y diagnosticar la respiracion irregular durante el sueño usando zonisamida y medio para llevar a cabo el metodo. | |
| Winkelman et al. | Current patterns and future directions in the treatment of insomnia | |
| JP2022534159A5 (https=) | ||
| CN114555070A (zh) | 月经周期诱发的症状治疗 | |
| Woo et al. | Holmes tremor after brainstem hemorrhage, treated with levodopa | |
| JP7123205B2 (ja) | 経口用医薬組成物 | |
| JP6514420B2 (ja) | 睡眠時無呼吸の処置のためのスルチアム | |
| JP2021530568A5 (https=) | ||
| US20190224208A1 (en) | Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation | |
| JP2024523876A5 (https=) | ||
| CN108371712B (zh) | 咖啡因与PPARγ激动剂联合制备AD药物中的用途 | |
| JP2022538170A5 (https=) | ||
| US20220370347A1 (en) | Treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease | |
| TW202508553A (zh) | 用於預防、減緩或治療睡眠障礙及／或與睡眠障礙相關之疾病的方法 | |
| Uppalapati et al. | 854 sexsomnia in a divorce proceeding and its custody implications | |
| CN121129884A (zh) | 维生素b复合物在制备治疗抗眩晕药物中的应用 | |
| Martínez et al. | CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) IN THE MANAGEMENT OF OBSTRUCTIVE SLEEP APNEA | |
| Goldberg | Parkinson’s Disease: A Neurodegenerative Disease |